Trial intelligence / Profile preview

Vitality: High-Dose Vitamin C in Advanced Colorectal Cancer

NCT02969681Phase 3Completed

Sponsor
Sun Yat-sen University
Start
Jan 2017
Primary completion
Dec 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial of ascorbic acid in metastatic colorectal cancer (mCRC) (2 arms), sponsored by Sun Yat-sen University. Primary endpoint: Progression Free Survival at 5 years. Started Jan 2017; status: completed.

02

Drugs

ascorbic acid
03

Conditions

metastatic colorectal cancer (mCRC)

Beyond the preview

Go deeper on NCT02969681.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02969681.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call